---
category: news
title: "Castle Biosciences Publishes DecisionDx®-Melanoma Study on the Validation of the i31-GEP SLNB Artificial Intelligence Algorithm"
excerpt: "Castle announced the publication of a study validating performance of the i31-SLNB algorithm to determine sentinel lymph node biopsy positivity risk."
publishedDateTime: 2021-11-06T01:00:00Z
originalUrl: "https://www.businesswire.com/news/home/20211105005811/en/Castle-Biosciences-Publishes-DecisionDx®-Melanoma-Study-on-the-Validation-of-the-i31-GEP-SLNB-Artificial-Intelligence-Algorithm"
webUrl: "https://www.businesswire.com/news/home/20211105005811/en/Castle-Biosciences-Publishes-DecisionDx®-Melanoma-Study-on-the-Validation-of-the-i31-GEP-SLNB-Artificial-Intelligence-Algorithm"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "8mV/piCaE50/usmw3uED05ZWgTAeuhjVXG8C8U7WzZ8rVYbbE2YFXONszLsXFIHY4yGGcYs7fDVFSDlITJUNi4gmfSfDUu2xPQ9+ByoCPhTpOp99hdiKhZibxyvMm/R79KW6rMctYaXLuMQL/aXJxSPaSmsmxikIpoA47sDU3PmW1t32IDIUenSDBRSttrofnQsvi64/+TtRUSUzrkZhpZ8NfVrUHW8TqzvxonuWW0wL5s98AJOT9IvSvQooU+EXraSYssCwTxNseYesJDPEK4snghe2qS1DXxrjQTjPdpfDtPio9mDzm+qEzFDYpSmE94Qr5YbnZhlOBcpbqxgkQf/Z6vFGPuO/wXzRUmX22YU=;UTRHxONIjEZaQHlM9pYgmw=="
---

